Testing effectiveness (Phase 2)Study completedNCT02310412
What this trial is testing
A Controlled, In Vivo, Pilot Study to Assess the Recovery and Survival of Radiolabeled Autologous INTERCEPT Treated 7-Day Stored Apheresis Platelet Components in 35% Plasma and 65% InterSol and 7-Day Stored Apheresis Platelet Components in 100% Plasma
Who this might be right for
Healthy
Cerus Corporation 14